P&K Skin Research Center피엔케이피부임상연구센타
347740 · KOSDAQ · ₩347740 · 피엔케이피부임상연구센타
₩1,811▼ ₩4 (0.22%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩6.6B | ₩6.2B | ₩5.8B | ₩5.1B | ₩5.5B | ₩6.5B | ₩5.1B | ₩4.7B |
| Cost of sales | ₩3.3B | ₩3.3B | ₩3B | ₩2.9B | ₩3.1B | ₩3.1B | ₩2.8B | ₩2.6B |
| Gross profit | ₩3.3B | ₩3B | ₩2.8B | ₩2.1B | ₩2.4B | ₩3.4B | ₩2.3B | ₩2.2B |
| Operating income | ₩1.5B | ₩959M | ₩752M | ₩452M | ₩825M | ₩1.9B | ₩739M | ₩731M |
| Net income | ₩1.5B | ₩1.5B | −₩906M | ₩1.6B | ₩1.6B | ₩2.3B | ₩1.1B | ₩2.3B |
| Net income to shareholders | ₩1.5B | ₩1.5B | −₩877M | ₩1.6B | ₩1.6B | ₩2.4B | ₩1.1B | ₩2.3B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩88B | ₩87B | ₩87B | ₩86B | ₩85B | ₩84B | ₩82B | ₩80B |
| Current assets | ₩41B | ₩49B | ₩46B | ₩48B | ₩42B | ₩46B | ₩48B | ₩52B |
| Cash and equivalents | ₩2.7B | ₩923M | ₩4B | ₩4.7B | ₩2.3B | ₩2.2B | ₩6.5B | ₩7.8B |
| Total liabilities | ₩6.2B | ₩6.8B | ₩6B | ₩4.5B | ₩4.9B | ₩5.7B | ₩5.2B | ₩4.6B |
| Current liabilities | ₩5.3B | ₩5.9B | ₩5B | ₩3.4B | ₩3.8B | ₩4.9B | ₩4.7B | ₩4.2B |
| Total equity | ₩82B | ₩81B | ₩80B | ₩81B | ₩80B | ₩78B | ₩77B | ₩76B |
| Shareholders' equity | ₩82B | ₩81B | ₩81B | ₩82B | ₩80B | ₩78B | ₩77B | ₩76B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩2.4B | ₩445M | ₩1.9B | ₩1.7B | ₩1.7B | ₩1.4B | ₩2.4B | ₩2.5B |
| Capital spending | −₩381M | −₩289M | −₩81M | −₩281M | −₩572M | −₩570M | −₩341M | −₩154M |
| Free cash flow | ₩2B | ₩156M | ₩1.8B | ₩1.4B | ₩1.2B | ₩783M | ₩2.1B | ₩2.4B |
| Dividends paid | ₩0 | −₩1.3B | ₩0 | ₩0 | ₩0 | −₩977M | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: P&K Skin Research Center / 피엔케이피부임상연구센타 / 347740 / KRX:347740
Source: KRX statistical information